Revolutionising cancer diagnostics Revolutionising cancer diagnostics

Revolutionising cancer diagnostics

A step change in the detection, diagnosis and monitoring of disease.

Biofidelity’s unique ASPYRE technology enables fast, simple and ultra-sensitive detection of genetic panels from both tissue and liquid biopsies using existing laboratory instrumentation.

Learn more about ASPYRE technology



Comprehensive coverage of NCCN guideline recommended markers for NSCLC

  • 111 markers across 11 genes
  • 0.1% allele-fraction sensitivity in a simple workflow
  • Simultaneous DNA & RNA analysis on one instrument

View product specification